Lung Adenocarcinoma - 25 Studies Found

Not yet recruiting : The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar
: Advanced Primary Lung Adenocarcinoma
: 2012-03-21
: Drug: endostar Endostar TM 7.5mg/m2,intravenous drip, Day 1to Day 10;Pemetrexed 500mg/m2, intravenous dr
Completed : A+C in Metastatic Lung Adenocarcinoma Cancer
: Lung Adenocarcinoma Metastatic
: 2016-10-24
: Drug: Crizotinib, bevacizumab Eligible patients with ALK translocation or ROS1 translocation or MET ampl
Not yet recruiting : Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas
: Metastatic Lung Adenocarcinomas
: 2016-08-24
: Other: Non intervention. Observation Study
Completed : Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma
: Lung Adenocarcinoma
: 2016-09-08
: Other: biopsies The biopsies of lung tumour samples will be analysed by immunochemistry (IHC), western b
Recruiting : Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
: Stage IV Lung Adenocarcinoma
: 2014-04-21
:
  • Drug: Certolizumab
  • Drug: cisplatin
Completed : Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
:
  • Lung Adenocarcinoma
  • Brain Metastases

: 2012-04-11
:
  • Drug: erlotinib 150 mg given o
Active, not recruiting : The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
: Adenocarcinoma of Lung
: 2015-07-07
:
  • Biological: Cytokine-Induced Killer Cells

Completed : Tepotinib Phase II Study in Lung Adenocarcinoma Harbouring MET Exon 14 (METex14) Skipping Alterations
: Lung Adenocarcinoma Stage IIIB/IV
: 2016-07-29
: Drug: tepotinib Subjects received 500 mg of tepotinib tablet once daily orally during each 21 day cycle
Completed : Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
: Adenocarcinoma of Lung
: 2016-06-15
:
  • Drug: recombinant human endostatin

Completed : Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
: Adenocarcinoma of Lung (Disorder)
: 2016-03-30
: Genetic: Sequencing of ctDNA in plasma Sequencing of ctDNA in plasma
<<< Previous | Next >>>